Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,870 total articles
CDT Equity Inc. (NASDAQ: CDT) announced a 1-for-25 reverse stock split effective March 26, 2026. This corporate action reduces the number of outstanding shares to roughly 4.72 million, with no change in the par value per share. The move, approved by both the board and shareholders, intends to adjust the share structure and maintain listing standard…
Linkers Industries Limited (Nasdaq: LNKS) announced a non-binding Memorandum of Understanding to acquire up to 29% equity in LPW Electronics Co. Ltd., a wire harness manufacturer in Thailand, increasing its stake to 49%. The acquisition aims to boost Linkers' manufacturing capacity, optimize economies of scale, and broaden its customer base, suppor…
Aemetis, Inc. announced that CEO Eric McAfee received the 2026 William C. Holmberg Memorial Award for Lifetime Achievement in the Bioeconomy. The award honors McAfee's longstanding leadership and contributions to renewable fuels and bioeconomy innovation. Aemetis is actively expanding its renewable natural gas, biofuels, sustainable aviation fuel, …
Purple Biotech announced a collaboration with AI-driven drug discovery company Converge Bio to accelerate and optimize its next-generation tri-specific antibody platform aimed at cancer treatment. The partnership leverages Converge Bio's generative AI technology to speed up molecule design, improve candidate quality, and expand the company's immuno…
ProMIS Neurosciences completed enrollment of 144 patients in its PRECISE-AD Phase 1b trial for Alzheimer’s disease, with positive safety results to date and anticipated interim data in Q3 2026 and top-line results in early 2027. The company secured up to $175 million in financing ensuring cash runway through 2027, accelerating development of a subc…
AEON Biopharma announced positive feedback from the FDA following their January 2026 Biosimilar Biological Product Development Type 2a meeting regarding the analytical similarity strategy for ABP-450, their biosimilar candidate to BOTOX®. The FDA recognized the scientific challenges but supported AEON's analytical approach under the 351(k) biosimil…
Catheter Precision, Inc. (NYSE American: VTAK) announced the expansion of its Flyte subsidiary's Vision Jet-powered Hops platform, aimed at creating a scalable, high-frequency short-haul regional travel solution. Flyte operates Cirrus Vision Jets optimized for under-500-mile routes, offering safety features like full-aircraft parachutes and autonom…
Aduro Clean Technologies Inc. has entered into a professional agreement with Water Tower Research LLC to receive research coverage and strategic investor engagement services aimed at increasing the company's visibility within institutional investment communities in the U.S. and internationally. The contract includes production of content and distri…
Avalyn Pharma announced peer-reviewed data from its Phase 1b ATLAS trial demonstrating that improvements in quantitative lung imaging correlate with better lung function and quality of life in patients with idiopathic pulmonary fibrosis treated with AP01. The findings mark the first dataset linking antifibrotic therapy imaging with clinical outcome…
Innovation Beverage Group Ltd. (Nasdaq: IBG) announced it has acquired a 51% controlling stake in Texas-based BlockFuel Energy Inc. This acquisition is a significant milestone toward a proposed merger that will create a rising oil producer and power generation company focusing on US onshore oil and gas operations and power generation for high-perfo…
ProQR Therapeutics announced a virtual investor and analyst event on April 8, 2026, to showcase its expanding RNA editing pipeline based on its proprietary Axiomer™ technology. The company plans to provide updates on the lead AX-0810 program targeting cholestatic diseases with anticipated initial Phase 1 data in the first half of 2026, unveil AX-08…
Incannex Healthcare has entered a partnership with the American Academy of Sleep Medicine Foundation to sponsor research in sleep apnea, reflecting its commitment to the field as it advances its lead investigational oral combination therapy, IHL-42X. The company recently achieved strong Phase 2 clinical results and received FDA Fast Track designati…
authID announced a strategic OEM partnership with a disruptive digital identity and continuous background screening tech company to embed its biometric identity verification and authentication technology into the partner's platform. This collaboration aims to provide organizations with reusable digital identity credentials that enable secure onboar…
LB Pharmaceuticals has commenced its pivotal Phase 3 NOVA-2 trial to evaluate LB-102, a novel oral benzamide antipsychotic candidate, for the treatment of schizophrenia in approximately 460 U.S. patients. LB-102 showed promising Phase 2 results with significant symptom improvement and a favorable safety profile. Topline data from NOVA-2 are expecte…
Getty Realty Corp., a US-based net lease REIT focused on convenience and automotive retail real estate, will release its Q1 2026 financial results on April 22, 2026, and host a concurrent earnings call on April 23, 2026. The company's portfolio comprises 1,174 properties across 44 states and Washington, D.C.
zSpace, Inc. highlights a successful partnership with Atlanta Public Schools, demonstrating the transformative power of its AR/VR learning platform in enhancing STEM education and career readiness across multiple school levels over nearly ten years. The immersive technology facilitates hands-on learning experiences that prepare students for workfor…
BullFrog AI Holdings has introduced bfARENAS™, a new AI-powered decision engine designed to support pharmaceutical and biotech companies in optimizing portfolio strategies and clinical trial designs. The tool evaluates options under multiple strategic scenarios, aiming to reduce risk and improve R&D decision-making efficiency amid clinical trial un…
Kestra Medical Technologies, a wearable medical device and digital healthcare firm, has been named a finalist in the 'Deal of the Year' category at the 2026 GeekWire Awards. The nomination recognizes Kestra's impactful 2025 initial public offering, which bolstered the company’s capacity to expand commercially and innovate its Cardiac Recovery Syste…
Kaltura has obtained ISO/IEC 42001 certification, the global standard for Artificial Intelligence Management Systems, recognizing its ability to manage AI-related risks including security and operational misuse. This certification enhances trust in Kaltura’s AI offerings, especially for customers in regulated sectors like financial services, health…
Recursion, a clinical-stage TechBio company, announced that Dr. Vicki Goodman will become Chief Medical Officer on April 6, 2026, succeeding Dr. David Mauro. Dr. Goodman brings extensive oncology drug development expertise from roles at biotech and major pharma companies, enhancing Recursion's leadership as it advances its clinical pipeline and pre…
BIO-key International, a leader in biometric authentication and identity access management solutions, announces its 2025 year-end earnings call scheduled for March 31st. The company will release financial results prior to the market opening, with senior executives hosting the conference call and Q&A session.
Artelo Biosciences announced a fully funded clinical study expanding its lead compound ART27.13 into the $16.3 billion glaucoma market, complementing its existing pipeline targeting oncology support, neuropathic pain, and CNS disorders. The company highlights positive interim Phase 2 data, European patent protection through 2041, supportive regulat…
EDAP TMS S.A. announced record fourth quarter and full-year 2025 revenue growth in its High-Intensity Focused Ultrasound (HIFU) business, with a 39% year-over-year increase driven by stronger global demand for the Focal One system. The company reported increased system sales, notably 14 cash sales in Q4, and 28% growth in U.S. Focal One procedures.…
Anavex Life Sciences has withdrawn its application for European marketing authorization of blarcamesine as an add-on treatment for early Alzheimer's disease after the EMA's Committee for Medicinal Products for Human Use indicated it would not issue a positive opinion at this time. The company plans to gather additional data and conduct further anal…
Creative Realities, Inc. (NASDAQ: CREX), a leading provider of digital signage and AdTech solutions, has appointed Jackie Walker as Chief Experience Officer. With over 15 years’ experience in digital transformation and expertise in retail media networks and QSR digital merchandising, Walker will lead the company’s transition into a software-first p…
